Skip to content

 

IDBS
Research and Development Software and Solutions
IDBS
  • Solutions
    • BioPharma Research & Discovery
    • BioPharma Development
    • Biopharma Manufacturing
    • Industrials
    • Energy
    • Agriculture
    • Food and Beverage
    • Consumer Goods
  • Products
    • E-WorkBook | Industrial R&D
    • Polar | Life Sciences R&D
    • Polar BioAnalysis
    • Polar BioProcess
    • Polar Insight
    • PIMS | Manufacturing
    • ActivityBase
  • Customers
    • Meet Our Customers
    • Customer Success Stories
  • IDBS ecosystem
    • Meet Our Partners
  • Resources
    • Knowledge Center
    • Training & Education
    • Glossary
  • About
    • History
    • Management Team
    • Certifications
    • Careers
    • Part of Danaher
    • Coordinated Vulnerability Disclosure
  • News
    • Events & Webinars
    • Blog
    • Press Releases

 

Contact UsDemo Request
  • Solutions
    • BioPharma Research & Discovery
    • BioPharma Development
    • Biopharma Manufacturing
    • Industrials
    • Energy
    • Agriculture
    • Food and Beverage
    • Consumer Goods
  • Products
    • E-WorkBook | Industrial R&D
    • Polar | Life Sciences R&D
    • Polar BioAnalysis
    • Polar BioProcess
    • Polar Insight
    • PIMS | Manufacturing
    • ActivityBase
  • Customers
    • Meet Our Customers
    • Customer Success Stories
  • IDBS ecosystem
    • Meet Our Partners
  • Resources
    • Knowledge Center
    • Training & Education
    • Glossary
  • About
    • History
    • Management Team
    • Certifications
    • Careers
    • Part of Danaher
    • Coordinated Vulnerability Disclosure
  • News
    • Events & Webinars
    • Blog
    • Press Releases
You are here:
  1. Home
  2. 2021
  3. June
  4. 15
Home News Archives for 15th June 2021 | 17:27
UTM:

coronavirus also known as covid-19 as shown under the microscope

Adapting to the Challenge COVID-19 Presents to Create a New Biopharma Normal

IDBS BlogBy Iris Barbier15th June 2021 | 17:27

In a recent Forbes article, Danaher’s Chief Science officer, Jose-Carlos Gutierrez-Ramos, described the impact of the COVID-19 pandemic as follows:“I believe the biopharma business model has fundamentally changed.

Terms of Use | Privacy Policy | Terms and Conditions | Do Not Sell or Share My Data | Cookie Settings
Danaher Life Sciences

Go to Top
Search

More results...

Generic filters
Exact matches only
Webinar: Digital data solutions for efficient immunogenicity analysis Register now
Webinar: Digital data solutions for efficient immunogenicity analysis Register now